Abstract: Botanical compounds to modulate kinase activity are disclosed. The compounds and methods disclosed also inhibit expression of COX-2, inhibit synthesis of prostaglandins selectively in target cells, and inhibit inflammatory response selectively. The compositions contain at least one fraction isolated or derived from hops or Acacia.
Type:
Grant
Filed:
August 9, 2006
Date of Patent:
September 11, 2012
Assignee:
Metaproteonics, LLC
Inventors:
Matthew L. Tripp, John G. Babish, Linda M. Pacioretty, Jeffrey S. Bland, Amy J. Hall, Veera Konda, Anu Desai
Abstract: A novel formulation is provided that serves to inhibit the inflammatory response in animals. The formulation comprises, as a first component an effective amount of a curcuminoid species and an effective amount of a second component selected from the group consisting of an alpha-acid species or a beta-acid species or derivatives thereof. The composition provides synergistic anti-inflammatory effects in response to physical or chemical injury or abnormal immune stimulation due to a biological agent or unknown etiology.
Type:
Grant
Filed:
November 13, 2004
Date of Patent:
October 9, 2007
Assignee:
Metaproteonics, LLC
Inventors:
John G. Babish, Terrence M. Howell, Linda M. Pacioretty